As a stable and reliable inflammatory marker, CRP has been shown to upregulate the expression of adhesion molecules and monocyte chemokines, inhibit the production of endothelial nitric oxide synthase (eNOS), and promote arterial thrombosis, indicating direct involvement in the occurrence of atherosclerosis [44–46]. This evidence concerns the gene CRP and atherosclerosis.